3-Thio-1,2,4-triazoles, novel somatostatin sst2/sst5 agonists

被引：41
|
作者：
Contour-Galcéra, MO [1 ]
Sidhu, A [1 ]
Plas, P [1 ]
Roubert, P [1 ]
机构：
[1] Inst Henri Beaufour, Ipsen Res Labs, F-91966 Les Ulis, France
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2005年 / 15卷 / 15期
关键词：
somatostatin agonist; somatostatin subtypes 2 and 5 agonist; 3-thio-triazole;
D O I：
10.1016/j.bmcl.2005.05.061
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Novel 3-thio-1,2,4-triazoles have been obtained via a solution-phase parallel synthesis strategy, affording potent non-peptidic human somatostatin receptor subtypes 2 and 5 agonists. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码：3555 / 3559
页数：5
相关论文
共 50 条
  • [1] Internalization of sst2, sst3, and sst5 receptors:: Effects of somatostatin agonists and antagonists
    Cescato, Renzo
    Schulz, Stefan
    Waser, Beatrice
    Eltschinger, Veronique
    Rivier, Jean E.
    Wester, Hans-Juergen
    Culler, Michael
    Ginj, Mihaela
    Liu, Qisheng
    Schonbrunn, Agnes
    Reubi, Jean Claude
    JOURNAL OF NUCLEAR MEDICINE, 2006, 47 (03) : 502 - 511
  • [2] Solid-supported syntheses of 3-thio-1,2,4-triazoles
    Michael W. Wilson
    Andrés S. Hernández
    Alain P. Calvet
    John C. Hodges
    Molecular Diversity, 1997, 3 : 95 - 112
  • [3] Solid-supported syntheses of 3-thio-1,2,4-triazoles
    Wilson, MW
    Hernandez, AS
    Calvet, AP
    Hodges, JC
    MOLECULAR DIVERSITY, 1998, 3 (02) : 95 - 112
  • [4] Subtype selective interactions of somatostatin and somatostatin analogs with sst1, sst2, and sst5 in BON-1 cells
    Eva Ludvigsen
    Mats Stridsberg
    John E. Taylor
    Michael D. Culler
    Kjell Öberg
    Eva T. Janson
    Medical Oncology, 2004, 21 : 285 - 295
  • [5] Subtype selective interactions of somatostatin and somatostatin analogs with sst1, sst2, and sst5 in BON-1 cells
    Ludvigsen, E
    Stridsberg, M
    Taylor, JE
    Culler, MD
    Öberg, K
    Janson, ET
    MEDICAL ONCOLOGY, 2004, 21 (03) : 285 - 295
  • [6] [125I][Tyr3]octreotide labels human somatostatin sst2 and sst5 receptors
    Siehler, S
    Seuwen, K
    Hoyer, D
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 348 (2-3) : 311 - 320
  • [7] The effect of selective sst1, sst2, sst5 somatostatin receptors agonists, a somatostatin/dopamine (SST/DA) chimera and bromocriptine on the "clinically non-functioning" pituitary adenomas in vitro
    Gruszka, A
    Kunert-Radek, J
    Radek, A
    Pisarek, H
    Taylor, J
    Dong, JZ
    Culler, MD
    Pawlikowski, M
    LIFE SCIENCES, 2006, 78 (07) : 689 - 693
  • [8] Quantitative determination of sst2 and sst5 gene expression in uterine leiomyomata and the effect of treatment with somatostatin analogue
    De Leo, V
    La Marca, A
    Vegni, V
    Raggi, CC
    Maggi, M
    Petraglia, F
    FERTILITY AND STERILITY, 2003, 80 (04) : 1058 - 1059
  • [9] Nonpeptidyl somatostatin agonists demonstrate that sst2 and sst5 inhibit stimulated growth hormone secretion from rat anterior pituitary cells
    Parmar, RM
    Chan, WWS
    Dashkevicz, M
    Hayes, EC
    Rohrer, SP
    Smith, RG
    Schaeffer, JM
    Blake, AD
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 263 (02) : 276 - 280
  • [10] Homologous and heterologous in vitro regulation of pig pituitary somatostatin receptor subtypes, sst1, sst2 and sst5 mRNA
    Luque, RM
    Park, S
    Peng, XD
    Delgado, E
    Gracia-Navarro, F
    Kineman, RD
    Malagón, MM
    Castaño, JP
    JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2004, 32 (02) : 437 - 448
12345